Match!
Parth Rali
Temple University
34Publications
2H-index
11Citations
Publications 36
Newest
Source
#1Parth RaliH-Index: 2
Last.Andreas FourasH-Index: 26
view all 9 authors...
Source
#1Parth Rali (TU: Temple University)H-Index: 2
#2A. Gangemi (TU: Temple University)H-Index: 1
Last.Lisa K. Moores (USU: Uniformed Services University of the Health Sciences)H-Index: 22
view all 5 authors...
The direct-acting oral anticoagulants (DOACs) have been increasingly used over vitamin K antagonists in recent years because they do not require monitoring and have an immediate anticoagulation effect. In general, DOACs have exhibited a better safety profile and noninferiority for prophylaxis and treatment of venous thromboembolism (VTE) and stroke prevention in patients with atrial fibrillation compared with vitamin K antagonists in the non-ICU population; whether this finding holds true in pat...
Source
#1E. Male (TU: Temple University)
#2S. Pettigrew (TU: Temple University)
Last.S. Dadparvar (TU: Temple University)
view all 8 authors...
Source
#2R. Vender (TU: Temple University)
Last.Parth RaliH-Index: 2
view all 13 authors...
Source
#1R. Alashram (TU: Temple University)
#2E.-O. Essien (TU: Temple University)
Last.Parth Rali (TU: Temple University)H-Index: 2
view all 16 authors...
Source
#1R. Alashram (TU: Temple University)
#2E. Male (TU: Temple University)
Last.Parth Rali (TU: Temple University)H-Index: 2
view all 15 authors...
Source
#1E.-O. Essien (TU: Temple University)
#2R. Alashram (TU: Temple University)
Last.Parth Rali (TU: Temple University)H-Index: 2
view all 12 authors...
Source
#2R. Vender (TU: Temple University)
Last.Parth RaliH-Index: 2
view all 13 authors...
Source
#1E. Male (TU: Temple University)
#2M.-I. Walshon (TU: Temple University)
Last.Parth Rali (TU: Temple University)H-Index: 2
view all 19 authors...
Source
1234